si why is the stock down. After Vringo won their marksman Vringo shot up $2 or more
worst example of a launch ever. Sanofi is showing they want to focus on Toujeo and don'r really care about Afrezza.
i'm sure activation wants this in court and activation knows that vringo just lost on appeal
With the terrible marketing job Sanofi has done its evident that MNKD could have done a the same or better job without Sanofi
Afrezza is even underperforming Exubera, the first inhaled insulin drug, launched by Pfizer in 2006. Exubera was a commercial failure, forcing Pfizer (PFE) to abandon the product after one year. With the terrible marketing job Sanofi has done its evident that MNKD could have done a the same or better job without Sanofi
and the idiot pumpers are still running their mouths here. You were done in and it wasn't the shorts who killed you. It was the board of directors who sold at every chance they could that drove the stock down.
I have a much more positive outlook on my career then I do for sales of Afrezza. And Wall Street doesn't make much of Afrezza either which is why it went from just under $11 to $5.64 and falling more
vringo was a mistake. I should have realized that Vringo would neve beat google because google has the money to buy justice.
The difference is that the companies that worlds is suing , don't have google's influence and WDDD and BCYP are trading at a fraction of what vringo was trading at . Wddd and BCYP are trading at pennies compared to the 3-4 that Vringo was trading at after the marksman trial.